Cargando…

A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression

BACKGROUND: The purpose of this research was to assess the role of heparanase (HPSE)/syndecan1 (SDC1)/nerve growth factor (NGF) on cancer pain from melanoma. METHODS: The influence of HPSE on the biological function of melanoma cells and cancer pain in a mouse model was evaluated. Immunohistochemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiaohu, Wang, Bingwu, Zhou, Zhaoyun, Li, Zixian, Tong, Song, Chen, Simin, Zhang, Nan, Liu, Su, Zhang, Maoyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812689/
https://www.ncbi.nlm.nih.gov/pubmed/36536517
http://dx.doi.org/10.3344/kjp.22277
_version_ 1784863783446904832
author Su, Xiaohu
Wang, Bingwu
Zhou, Zhaoyun
Li, Zixian
Tong, Song
Chen, Simin
Zhang, Nan
Liu, Su
Zhang, Maoyin
author_facet Su, Xiaohu
Wang, Bingwu
Zhou, Zhaoyun
Li, Zixian
Tong, Song
Chen, Simin
Zhang, Nan
Liu, Su
Zhang, Maoyin
author_sort Su, Xiaohu
collection PubMed
description BACKGROUND: The purpose of this research was to assess the role of heparanase (HPSE)/syndecan1 (SDC1)/nerve growth factor (NGF) on cancer pain from melanoma. METHODS: The influence of HPSE on the biological function of melanoma cells and cancer pain in a mouse model was evaluated. Immunohistochemical staining was used to analyze HPSE and SDC1. HPSE, NGF, and SDC1 were detected using western blot. Inflammatory factors were detected using ELISA assay. RESULTS: HPSE promoted melanoma cell viability, proliferation, migration, invasion, and tumor growth, as well as cancer pain, while SST0001 treatment reversed the promoting effect of HPSE. HPSE up-regulated NGF, and NGF feedback promoted HPSE. High expression of NGF reversed the inhibitory effect of HPSE down-regulation on melanoma cell phenotype deterioration, including cell viability, proliferation, migration, and invasion. SST0001 down-regulated SDC1 expression. SDC1 reversed the inhibitory effect of SST0001 on cancer pain. CONCLUSIONS: The results showed that HPSE promoted melanoma development and cancer pain by interacting with NGF/SDC1. It provides new insights to better understand the role of HPSE in melanoma and also provides a new direction for cancer pain treatment.
format Online
Article
Text
id pubmed-9812689
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Pain Society
record_format MEDLINE/PubMed
spelling pubmed-98126892023-01-11 A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression Su, Xiaohu Wang, Bingwu Zhou, Zhaoyun Li, Zixian Tong, Song Chen, Simin Zhang, Nan Liu, Su Zhang, Maoyin Korean J Pain Experimental Research Articles BACKGROUND: The purpose of this research was to assess the role of heparanase (HPSE)/syndecan1 (SDC1)/nerve growth factor (NGF) on cancer pain from melanoma. METHODS: The influence of HPSE on the biological function of melanoma cells and cancer pain in a mouse model was evaluated. Immunohistochemical staining was used to analyze HPSE and SDC1. HPSE, NGF, and SDC1 were detected using western blot. Inflammatory factors were detected using ELISA assay. RESULTS: HPSE promoted melanoma cell viability, proliferation, migration, invasion, and tumor growth, as well as cancer pain, while SST0001 treatment reversed the promoting effect of HPSE. HPSE up-regulated NGF, and NGF feedback promoted HPSE. High expression of NGF reversed the inhibitory effect of HPSE down-regulation on melanoma cell phenotype deterioration, including cell viability, proliferation, migration, and invasion. SST0001 down-regulated SDC1 expression. SDC1 reversed the inhibitory effect of SST0001 on cancer pain. CONCLUSIONS: The results showed that HPSE promoted melanoma development and cancer pain by interacting with NGF/SDC1. It provides new insights to better understand the role of HPSE in melanoma and also provides a new direction for cancer pain treatment. The Korean Pain Society 2023-01-01 2023-01-01 /pmc/articles/PMC9812689/ /pubmed/36536517 http://dx.doi.org/10.3344/kjp.22277 Text en © The Korean Pain Society, 2023 https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Experimental Research Articles
Su, Xiaohu
Wang, Bingwu
Zhou, Zhaoyun
Li, Zixian
Tong, Song
Chen, Simin
Zhang, Nan
Liu, Su
Zhang, Maoyin
A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title_full A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title_fullStr A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title_full_unstemmed A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title_short A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
title_sort positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression
topic Experimental Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812689/
https://www.ncbi.nlm.nih.gov/pubmed/36536517
http://dx.doi.org/10.3344/kjp.22277
work_keys_str_mv AT suxiaohu apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT wangbingwu apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhouzhaoyun apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT lizixian apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT tongsong apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT chensimin apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhangnan apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT liusu apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhangmaoyin apositivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT suxiaohu positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT wangbingwu positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhouzhaoyun positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT lizixian positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT tongsong positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT chensimin positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhangnan positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT liusu positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression
AT zhangmaoyin positivefeedbackloopofheparanasesyndecan1nervegrowthfactorregulatescancerpainprogression